Related Experiment Video
Updated: Aug 9, 2025

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Ormdl3 regulation of specific ceramides is dispensable for β-cell function and glucose homeostasis under obesogenic
Liam D Hurley1, Hugo Lee1, Gina Wade2
1Department of Biomolecular Chemistry, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI 53706, USA.
Abstract:
Chronic elevation of sphingolipids contributes to β-cell failure. ORMDL3 has been identified as a key regulator of sphingolipid homeostasis, however, its function in pancreatic β-cell pathophysiology remains unclear. Here, we generated a mouse model lacking Ormdl3 within pancreatic β-cells ( Ormdl3 β-/- ). We show that loss of β-cell Ormdl3 does not alter glucose tolerance, insulin sensitivity, insulin secretion, islet morphology, or cellular ceramide levels on standard chow diet. When challenged with a high fat diet, while Ormdl3 β-/- mice did not exhibit any alteration in metabolic parameters or islet architecture, lipidomics analysis revealed significantly higher levels of very long chain ceramides in their islets. Taken together, our results reveal that loss of Ormdl3 alone is not sufficient to impinge upon β-cell function or whole-body glucose and insulin homeostasis, but loss of Ormdl3 does alter specific sphingolipid levels.
Insights
Loss of ORMDL3 in pancreatic beta cells did not affect glucose homeostasis or insulin secretion. However, it altered very long chain ceramide levels in islets under high-fat diet conditions.
Area of Science:
- Endocrinology
- Metabolic Disease Research
- Cell Biology
Background:
- Sphingolipids are crucial for cellular function, and their chronic elevation is linked to pancreatic beta-cell failure.
- ORMDL3 is a key regulator of sphingolipid homeostasis, but its specific role in beta-cell pathophysiology is not well understood.
Approach:
- Generated a mouse model with beta-cell specific deletion of Ormdl3 (Ormdl3β-/-).
- Assessed metabolic parameters (glucose tolerance, insulin sensitivity), insulin secretion, and islet morphology under standard and high-fat diet conditions.
- Utilized lipidomics to analyze ceramide levels in islets.
Key Points:
- Loss of beta-cell Ormdl3 did not impact glucose tolerance, insulin sensitivity, insulin secretion, or islet morphology on a standard diet.
- High-fat diet challenge in Ormdl3β-/- mice revealed significantly higher levels of very long chain ceramides in islets.
- No alterations in overall metabolic parameters or islet architecture were observed in Ormdl3β-/- mice even under high-fat diet.
Conclusions:
- Loss of Ormdl3 alone is insufficient to impair beta-cell function or whole-body glucose and insulin homeostasis.
- Ormdl3 deficiency specifically alters very long chain ceramide levels within pancreatic islets.
- Further research is needed to elucidate the precise role of ORMDL3 in sphingolipid metabolism and beta-cell health.
More Related Videos
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Cell Specific Gene Expression
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

